Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Alps Medical Breakthroughs ETF (SBIO)

Alps Medical Breakthroughs ETF (SBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family ALPS Holdings
  • Assets Under Management 167,500,000
  • Market Capitalization, $K 167,500
  • Shares Outstanding, K 5,000
  • 60-Month Beta 1.60
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.78 (2.39%)
  • Most Recent Dividend 0.784 on 12/20/18
  • Management Fee 0.50%
  • Sectors:

    ETFs - Healthcare

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.14 +9.02%
on 10/02/19
36.18 -9.18%
on 09/19/19
-2.97 (-8.29%)
since 09/18/19
3-Month
30.14 +9.02%
on 10/02/19
36.72 -10.51%
on 09/12/19
-3.33 (-9.20%)
since 07/18/19
52-Week
25.49 +28.91%
on 12/24/18
37.40 -12.14%
on 04/05/19
-3.15 (-8.75%)
since 10/18/18

Most Recent Stories

More News
Top-Performing Biotech ETFs YTD

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.

RHHBY : 36.8100 (+0.68%)
BMY : 53.03 (+1.16%)
XBI : 78.65 (-1.21%)
BTEC : 31.64 (+0.76%)
BBH : 120.96 (-0.15%)
SBIO : 32.86 (-1.91%)
ILMN : 309.44 (-0.36%)
CELG : 102.95 (+1.13%)
GILD : 64.91 (-0.49%)
GLPG : 157.02 (-3.67%)
AMGN : 202.72 (-0.41%)
EC : 16.95 (-1.11%)
ARKG : 28.42 (-2.24%)
Why These Innovative Biotech ETFs Soaring

Strong M&A activity has sent shares of many small, innovative biotech companies surging

NVTA : 17.41 (-4.65%)
PFE : 36.46 (unch)
MRK : 84.68 (+1.05%)
LLY : 108.64 (+0.17%)
BMY : 53.03 (+1.16%)
BTEC : 31.64 (+0.76%)
SBIO : 32.86 (-1.91%)
ILMN : 309.44 (-0.36%)
ARRY : 47.85 (unch)
CELG : 102.95 (+1.13%)
ARKG : 28.42 (-2.24%)
Markets & ETFs Digest Trade Spat: Is It a Dead-Cat-Bounce?

Though markets rallied probably on the undervalued status and a still-steady US economy, rising recessionary fears and full-scale trade war risks should brighten the appeal of safer ETFs.

DIV : 23.38 (+0.34%)
PEK : 39.45 (-1.68%)
SMH : 122.10 (-0.98%)
SBIO : 32.86 (-1.91%)
AIA : 60.28 (-0.99%)
ACWI : 74.46 (-0.33%)
OIH : 11.10 (-1.25%)
JJG : 46.04 (+0.13%)
PTF : 69.05 (-1.88%)
EEM : 41.98 (-0.52%)
SOYB : 15.93 (+0.38%)
BAB : 31.98 (-0.06%)
GLD : 140.46 (-0.11%)
XES : 6.75 (-1.89%)
SPLV : 57.51 (+0.31%)
Markets & ETFs Digest Trade Spat: Is It a Dead-Cat-Bounce?

Though markets rallied probably on the undervalued status and a still-steady US economy, rising recessionary fears and full-scale trade war risks should brighten the appeal of safer ETFs.

DIV : 23.38 (+0.34%)
PEK : 39.45 (-1.68%)
SMH : 122.10 (-0.98%)
SBIO : 32.86 (-1.91%)
AIA : 60.28 (-0.99%)
ACWI : 74.46 (-0.33%)
OIH : 11.10 (-1.25%)
JJG : 46.04 (+0.13%)
PTF : 69.05 (-1.88%)
EEM : 41.98 (-0.52%)
SOYB : 15.93 (+0.38%)
BAB : 31.98 (-0.06%)
GLD : 140.46 (-0.11%)
XES : 6.75 (-1.89%)
SPLV : 57.51 (+0.31%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

NVS : 86.88 (-0.40%)
LLY : 108.64 (+0.17%)
RHHBY : 36.8100 (+0.68%)
PFE : 36.46 (unch)
JNJ : 127.70 (-6.22%)
SBIO : 32.86 (-1.91%)
BTEC : 31.64 (+0.76%)
BBP : 36.26 (-0.45%)
XBI : 78.65 (-1.21%)
ONCE : 100.04 (-0.94%)
ILMN : 309.44 (-0.36%)
ARKG : 28.42 (-2.24%)
Biotechnology Market on a Tear: 5 ETFs in Spotlight

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

NVS : 86.88 (-0.40%)
LLY : 108.64 (+0.17%)
RHHBY : 36.8100 (+0.68%)
PFE : 36.46 (unch)
JNJ : 127.70 (-6.22%)
SBIO : 32.86 (-1.91%)
BTEC : 31.64 (+0.76%)
BBP : 36.26 (-0.45%)
XBI : 78.65 (-1.21%)
ONCE : 100.04 (-0.94%)
ILMN : 309.44 (-0.36%)
ARKG : 28.42 (-2.24%)
Top ETF Stories of February

Inside the top ETF events of the month of February.

RHHBY : 36.8100 (+0.68%)
CNXT : 26.82 (-1.37%)
DIA : 267.64 (-1.01%)
VWO : 41.40 (-0.26%)
ITOT : 67.37 (-0.38%)
EUFN : 18.47 (+0.49%)
DFE : 58.56 (+0.47%)
FXB : 125.50 (+0.55%)
SBIO : 32.86 (-1.91%)
BTEC : 31.64 (+0.76%)
FEP : 35.42 (+0.27%)
IPO : 27.93 (-2.21%)
BBP : 36.26 (-0.45%)
PEK : 39.45 (-1.68%)
Q : 103.48 (+0.55%)
Top ETF Stories of February

Inside the top ETF events of the month of February.

RHHBY : 36.8100 (+0.68%)
CNXT : 26.82 (-1.37%)
DIA : 267.64 (-1.01%)
VWO : 41.40 (-0.26%)
ITOT : 67.37 (-0.38%)
EUFN : 18.47 (+0.49%)
DFE : 58.56 (+0.47%)
FXB : 125.50 (+0.55%)
SBIO : 32.86 (-1.91%)
BTEC : 31.64 (+0.76%)
FEP : 35.42 (+0.27%)
IPO : 27.93 (-2.21%)
BBP : 36.26 (-0.45%)
PEK : 39.45 (-1.68%)
Q : 103.48 (+0.55%)
Biotech ETFs Jump on Roche-Spark Deal

The news of Roche-Spark Deal has triggered speculations of merger wave in the gene therapy industry and pushed the biotech ETFs higher.

RHHBY : 36.8100 (+0.68%)
NVS : 86.88 (-0.40%)
PBE : 48.61 (-0.94%)
SBIO : 32.86 (-1.91%)
XBI : 78.65 (-1.21%)
QURE : 42.96 (-2.85%)
ONCE : 100.04 (-0.94%)
BLUE : 89.53 (-1.97%)
BOLD : 26.85 (-0.89%)
SLDB : 11.80 (-3.91%)
CRSP : 37.91 (unch)
ARKG : 28.42 (-2.24%)
Biotech ETFs Jump on Roche-Spark Deal

The news of Roche-Spark Deal has triggered speculations of merger wave in the gene therapy industry and pushed the biotech ETFs higher.

RHHBY : 36.8100 (+0.68%)
NVS : 86.88 (-0.40%)
PBE : 48.61 (-0.94%)
SBIO : 32.86 (-1.91%)
XBI : 78.65 (-1.21%)
QURE : 42.96 (-2.85%)
ONCE : 100.04 (-0.94%)
BLUE : 89.53 (-1.97%)
BOLD : 26.85 (-0.89%)
SLDB : 11.80 (-3.91%)
CRSP : 37.91 (unch)
ARKG : 28.42 (-2.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

See More Share

Trade SBIO with:

Fund Summary

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200...

See More

Key Turning Points

2nd Resistance Point 33.95
1st Resistance Point 33.41
Last Price 32.86
1st Support Level 32.45
2nd Support Level 32.03

See More

52-Week High 37.40
Last Price 32.86
Fibonacci 61.8% 32.85
Fibonacci 50% 31.44
Fibonacci 38.2% 30.04
52-Week Low 25.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar